Kuehn Law Launches Inquiry into Rhythm Pharmaceuticals Governance

The inquiry targets the conduct of certain officers and directors at Rhythm Pharmaceuticals. While the firm represents shareholders in potential litigation, they emphasize that the consultation process remains free of charge, with all case costs covered by the legal team. Justin Kuehn, the lead attorney on the matter, is currently soliciting contact from current investors to discuss the scope of the investigation.

Shareholders who believe their interests have been harmed are urged to reach out to the Southampton-based practice. The firm maintains that active participation in such derivative litigation serves to preserve market integrity, though they note that legal timelines for enforcing shareholder rights may be limited. Interested parties can contact the firm via email or phone to review their standing in the case.